The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...

Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S. Food and Drug Administration (FDA) qualification of two new clinical outcome assessment tools: the Asthma ...

DARIEN, IL - The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom ...

AA-IGA and Scalp Hair Assessment PRO stratify severity into five categories, with the PRO enabling patient-centered monitoring and treatment personalization. AASc and ASAMI incorporate extra-scalp ...

The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom progression in ...

The primary assessment of myositis includes core set measures of disease activity and disease damage and measures of patient-reported outcomes. A new composite myositis response criterion, which ...

Use of a new asthma assessment tool called APGAR leads to improved asthma control and improved patient outcomes in terms of asthma-related emergency, urgent care, and hospital visits, according to a ...

Therefore, patient-centered outcome assessment tools applicable for both clinic and research should be developed. Report of symptoms via digital media provides a start for face-to-face communication, ...

A Purdue University precision innovation developed for brain tumor surgery is being expanded to provide medical professionals with a rapid, robust supplemental assessment tool to more efficiently ...

The American Academy of Sleep Medicine has developed and validated a patient-reported outcome tool for use in a clinical setting to monitor treatment response and longitudinal symptom progression in ...